Missense mutations in the fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis

Blood

Volumn 89, Issue 3, 1997, Pages 902-909

  Bettinardi, Alessandra ^b   Brugnoni, Duilio ^a   Quiròs Roldan, Eugenia ^b   Malagoli, Alberto ^b   La Grutta, Stefania ^b   Correra, Antonio ^b   Notarangelo, Luigi D ^b  

^a SPEDALI CIVILI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADOLESCENT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CASE REPORT; CHILD; DIAGNOSIS; HLA SYSTEM; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SPLENOMEGALY;

EID: 0030952229     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.3.902     Document Type: Article

References (43)

1. Strasser A: Life and death during lymphocyte development and function: Evidence for two distinct killing mechanisms. Curr Opin Immunol 7:228, 1995
2. Russel JH: Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 7:382, 1995
3. Mountz JD, Zhou T, Wu J, Wang W, Su X, Cheng J: Regulation of apoptosis in immune cells. J Clin Immunol 15:1, 1995
4. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Path M, Daniel PT, Knipping E, Westendorp MO, Stricker K, Bäumler C, Hellbardt S, Germer M, Peter ME, Debatin K-M: The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 142:175, 1994
5. Nagata S, Golstein P: The Fas death factor. Science 267:1449, 1995
6. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH: Monoclonal-antibody-mediated tumor regression by induction of apoptosis. Science 245:301, 1989
7. Dhein J, Daniel PT, Trauth BC, Ohem A, Moeller P, Krammer PH: Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 149:3166, 1992
8. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
9. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179:873, 1994
10. Tartaglia L, Ayres TM, Wong JHV, Goeddel DV: A novel domain within the 55kd TNF receptor signals cell death. Cell 74:845, 1993
11. Itoh N, Nagata S: A novel protein domain required for apoptosis. J Biol Chem 268:10932, 1993
12. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins A, Nagata S: Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314, 1992
13. cg, that complements the gld gene in induction of lymphadenopathy in the mouse. J Exp Med 171:519, 1990
14. Singer GG, Carrera AC, Marschak-Rothstein A, Martinez-A C, Abbas AK: Apoptosis, Fas and systemic autoimmunity: The MRL-lpr/lpr model. Curr Opin Immunol 6:913, 1994
15. Nagata S, Suda T: Fas and Fas ligand: lpr and gld mutations. Immunol Today 16:39, 1995
16. Rieux-Laucaut F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347, 1995
17. Fisher GH, Rosemberg FJ, Straus SE, Dale JK, Middleton LA, Lin AJ, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935, 1995
18. Harris EN: The Second International Anticardiolipin Standardization Workshop/The Kingston Antiphospholipid Antibody Study (KAPS) group. Am J Clin Pathol 94:476, 1990
19. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
20. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225, 1992
21. Martin R, Howell MD, Jaraquemada D, Flerlage M, Richert J, Brostoff S, Long EO, McFarlin DE, McFarland HF: A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 173:19, 1991
22. Bettinardi A, Sottini A, Imberti L, Primi D: Analysis of amplified T cell receptor Vβ transcripts by a non-isotopic immunoassay. J Immunol Methods 146:71, 1992
23. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
24. Oehm A, Behrmamm I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponsting H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: Sequence identity with the Fas antigen. J Biol Chem 267:10709, 1992
25. Cheng J, Liu C, Koopman JW, Mountz JD: Characterization of human Fas gene. Exon/Intron organization and promoter region. J Immunol 154:1239, 1995
26. Fiucci G, Ruberti G: Detection of polymorphisms within the Fas cDNA gene sequence by GC-clamp denaturating gradient gel electrophoresis. Immunogenetics 39:437, 1994
27. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274, 1992
28. Rathmell JC, Goodnow CC: The Fas track. Curr Biol 11:1218, 1995
29. Nemanzee DA, Studer S, Steinmetz M, Dembic Z, Kiefer M: The lymphoproliferating cells of MRL-lpr/lpr mice are a polyclonal population that bear the T lymphocyte receptor for antigen. Eur J Immunol 15:760, 1985
30. Bretscher P, Cohn M: A theory of self-nonself discrimination. Science 169:1042, 1970
31. Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion versus functional clonal inactivation: A costimulatory pathway determines the outcome of T cell receptor occupancy. Annu Rev Immunol 7:445, 1989
32. Ledbetter JA, Deans JP, Aruffo A, Grossmaire LS, Kanner SB, Bolen JB, Schieven GL: CD4, CD8 and the role of CD45 in T-cell activation. Curr Opin Immunol 5:334, 1993
33. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191, 1993
34. Tutt-Landolfi MM, Van Houten N, Russel JQ, Scollay R, Padness JR, Budd RC: CD2-CD4-CD8-lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor. J Immunol 151:1086, 1993
35. low cells. J Immunol 153:3948, 1994
36. Sobel ES, Kakkanaiah VN, Rapoport RG, Eisenberg RA, Cohen PL: The abnormal lpr double-negative T cell fails to proliferate in vivo. Clin Immunol Immunopathol 74:177, 1995
37. Giese T, Davidson WF: CD8+ T cell deficient lpr/lpr mice, CD4+, B220+ and CD4+ B220-T cells replace B220+ double negative T cells as the predominant population in enlarged lymph nodes. J Immunol 154:4986, 1995
38. Stafford-Brady F, Sugiyama E, Robinson DR, Sy M-S, Bonventre JW, Yeh ETH: Defective signal transduction in CD4-CD8-T cells of lpr mice. Cell Immunol 123:396, 1989
39. Altman A, Theofilopoulos AN, Weiner R, Katz DH, Dixon FJ: Analysis of T cell function in autoimmune murine strains: Defects in production of and responsivness to interleukin-2. J Exp Med 154:791, 1981
40. Sneller MC, Straus SE, Jaffe ES, Jaffe JS, Fleisher TA, Stetler-Stevenson M, Strober W: A novel lymphoproliferative autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334, 1992
41. Tomita-Yamaguchi M, Santoro TJ: Constitutive turnover of inositol-containing phospholipids in B220+ T cells from autoimmune-prone MRL-lpr/lpr mice. J Immunol 144:3946, 1990
42. Budd RC, Winslow G, Inokuchi S, Imboden JB: Intact antigen receptor mediated generation of inositol phosphates and increased intracellular calcium in CD4-8-T lymphocytes from MRL-lpr mice. J Immunol 145:2862, 1990
43. L. Immunity 3:87, 1995